Today: 19 May 2026
Browse Category

NYSE:TMO 23 January 2026 - 15 February 2026

Thermo Fisher (TMO) stock nudges higher after filing for new bond sale tied to Clario deal

Thermo Fisher (TMO) stock nudges higher after filing for new bond sale tied to Clario deal

Thermo Fisher shares rose 0.1% to $543.48 Monday after the company filed for a four-part senior notes offering to help fund its planned Clario acquisition. The preliminary prospectus left key terms blank and showed $39.38 billion in consolidated debt as of Dec. 31, 2025. S&P rated the proposed debt ‘A-’. Executive Gianluca Pettiti filed to sell 400 shares valued at $216,480.
9 February 2026
Thermo Fisher stock price: TMO ends week near $543 — what matters before Monday’s open

Thermo Fisher stock price: TMO ends week near $543 — what matters before Monday’s open

Thermo Fisher shares closed Friday at $542.83, up 0.09% for the day but down 6.7% since Feb. 2 after a steep midweek drop. The company’s 2026 forecast cited pressure from U.S. academic research funding cuts and projected adjusted profit of $24.22 to $24.80 a share. The planned $8.9 billion Clario acquisition is expected to close by mid-2026. Broader sector peers outperformed Thermo Fisher into the weekend.
8 February 2026
Thermo Fisher stock price today: TMO nudges higher after Thursday drop as investors eye next week’s data

Thermo Fisher stock price today: TMO nudges higher after Thursday drop as investors eye next week’s data

Thermo Fisher shares rose 0.6% to $545.58 Friday afternoon, recovering some ground after a 4% drop Thursday. The move lagged the broader market, with the S&P 500 up 1.73%. Investors remain cautious amid weak academic research funding and uncertain lab order trends. Upcoming U.S. jobs and inflation data could affect rate expectations and valuations.
6 February 2026
Thermo Fisher Scientific stock price slides to $578.61 after 2026 outlook; what to watch Monday

Thermo Fisher Scientific stock price slides to $578.61 after 2026 outlook; what to watch Monday

Thermo Fisher Scientific shares fell 2.29% to $578.61 Friday, extending a four-day slide after issuing a cautious 2026 outlook and forecasting earnings below Wall Street’s average estimate. Volume reached 3.7 million shares, nearly double the daily average. The company cited continued pressure from frozen academic research grants. Fourth-quarter revenue rose 7% to $12.21 billion, with adjusted EPS at $6.57.
31 January 2026
Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher shares edged up 0.1% to $219.83 Friday after steep losses earlier in the week. The company reported Q4 revenue of $6.84 billion and adjusted EPS of $2.23, with 2026 earnings guidance in line with analyst forecasts. Investors remain cautious amid weak academic research funding and recent stock swings. Vanguard disclosed an 8.63% stake in Danaher as of Dec. 31.
Thermo Fisher stock slides on 2026 profit outlook as research funding cuts bite — what’s next for TMO

Thermo Fisher stock slides on 2026 profit outlook as research funding cuts bite — what’s next for TMO

Thermo Fisher shares fell 2.6% to $592.16 after the company forecast 2026 profits below Wall Street estimates, citing weaker U.S. academic research funding. The company projected adjusted earnings of $24.22 to $24.80 per share, missing consensus. Fourth-quarter revenue rose 7% to $12.21 billion, beating expectations. CFO Stephen Williamson will retire in March, with Jim Meyer named as successor.
30 January 2026
Thermo Fisher (TMO) stock drops after 2026 profit outlook misses on research funding cuts

Thermo Fisher (TMO) stock drops after 2026 profit outlook misses on research funding cuts

Thermo Fisher shares fell 2.6% to $592.08 after the company forecast 2026 adjusted profit below Wall Street estimates, citing continued weakness in U.S. academic and government funding. The firm projected 2026 adjusted EPS of $24.22–$24.80 and revenue of $46.3–$47.2 billion. Fourth-quarter revenue rose 7% to $12.21 billion. Investors are watching the timing of the Clario acquisition, expected to close by mid-2026.
Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher shares fell 2.55% to $608.02 Wednesday, their second straight decline ahead of Thursday’s Q4 earnings call. Trading volume topped 2.3 million, above average, as investors weighed Danaher’s warning on weak academic research funding. The stock now sits 5.6% below its Jan. 22 high. Life-science tools stocks broadly declined during the session.
Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher shares rose 0.8% to $631.24 by midday Monday in New York, rebounding from an early dip ahead of Thursday’s earnings report and 2026 outlook. Options markets point to an expected 4% swing after results. Analysts forecast Q4 earnings of $6.43 per share, up from $6.10 a year ago. The company will hold its earnings call at 8:30 a.m. ET on Jan. 29.
Thermo Fisher (TMO) stock slips from fresh high as earnings week and Fed decision loom

Thermo Fisher (TMO) stock slips from fresh high as earnings week and Fed decision loom

Thermo Fisher shares fell 2.11% to $625.98 Friday, ending a three-day rally and closing 2.8% below Thursday’s 52-week high. The company reports earnings before the market opens Jan. 29, following Danaher’s results and the Fed’s Jan. 27-28 meeting. The S&P 500 health care index slipped 0.56% Friday. Analyst consensus expects Thermo Fisher to post $6.44 EPS on $11.95 billion revenue for the quarter.
Thermo Fisher (TMO) stock pulls back from a fresh high as Jan. 29 earnings loom

Thermo Fisher (TMO) stock pulls back from a fresh high as Jan. 29 earnings loom

Thermo Fisher Scientific shares fell 2.1% to $625.98 on Friday, reversing after a 52-week high the previous day. Trading volume was above average as investors positioned ahead of next week’s earnings and a Federal Reserve meeting. The company’s 1.400% senior notes due 2026 are being delisted from the NYSE. Thermo Fisher reports fourth-quarter results before markets open on Jan. 29.
Thermo Fisher stock slips from fresh high — what traders watch before earnings week

Thermo Fisher stock slips from fresh high — what traders watch before earnings week

Thermo Fisher Scientific shares fell 2.1% to $625.98 Friday, ending a three-day rally and retreating from a 52-week high. The drop came ahead of the company’s Jan. 29 earnings release and as peers Waters and Danaher also declined about 2%, signaling profit-taking in the life-sciences tools sector. Investors await updates on Thermo Fisher’s planned Clario acquisition and outlook for 2026.
Thermo Fisher (TMO) stock slides as investors square up ahead of Jan. 29 results

Thermo Fisher (TMO) stock slides as investors square up ahead of Jan. 29 results

Thermo Fisher Scientific shares fell nearly 2% by midday Friday, reversing earlier gains after touching a record high near $640. The drop outpaced the broader market, with peers Danaher, Agilent, and Illumina also declining. Investors are awaiting Thermo Fisher’s fourth-quarter results, set for release before the market opens on Jan. 29. The S&P 500 was steady while the health-care sector slipped.
Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings

Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings

Thermo Fisher Scientific shares fell 1.2% to $631.70 in late morning trading Friday, ending a two-day rally as investors awaited the company’s Jan. 29 earnings report. Peers Danaher and Agilent also declined. Traders are watching for management’s outlook on demand and margins. A recent minor debt security filing drew some attention but did not involve common stock.
Thermo Fisher stock price holds near a fresh 52-week high with earnings next week in focus

Thermo Fisher stock price holds near a fresh 52-week high with earnings next week in focus

Thermo Fisher shares closed up 0.5% at $639.43 Thursday after hitting a new 52-week high, with little change in after-hours trading. The company will report fourth-quarter and full-year results before the market opens Jan. 29. Investors are watching for signals on lab and biopharma spending. Peers Danaher and Agilent slipped, while Waters rose late Thursday.
1 2 3 4

Stock Market Today

  • Hecla Mining Shares Drop Below 200-Day Moving Average
    May 19, 2026, 5:21 PM EDT. Shares of Hecla Mining Co (HL) fell below their 200-day moving average of $4.93 on Thursday, hitting a low of $4.74 and closing down about 3.5%. The 200-day moving average is a technical indicator used to assess a stock's long-term trend by averaging its price over the past 200 trading days. HL's current price of $4.80 sits between its 52-week range low of $3.41 and high of $7.66. This breach signals potential bearish momentum for Hecla Mining as investors react to the stock's recent performance.

Latest articles

SMCI Stock Alert: Super Micro Slips as Sales Shake-Up Tests AI Server Rally

SMCI Stock Alert: Super Micro Slips as Sales Shake-Up Tests AI Server Rally

19 May 2026
Super Micro Computer shares fell 0.9% to $30.56 Tuesday after a filing showed longtime sales chief Don Clegg retired, effective May 15. The company named Matthew Thauberger as chief revenue officer last week. Super Micro reported third-quarter net sales of $10.2 billion, up from $4.6 billion a year earlier, but missed Wall Street revenue estimates.
Keysight Shares Surge as Orders Hit Record High

Keysight Shares Surge as Orders Hit Record High

19 May 2026
Keysight Technologies shares climbed nearly 4% in after-hours trading Tuesday after reporting fiscal Q2 revenue of $1.72 billion and adjusted earnings of $2.87 per share, beating analyst estimates. Orders rose to $2.05 billion from $1.32 billion a year earlier. The stock closed at $344.11, then traded at $357.80 after the bell. S&P 500 and Nasdaq both fell during the session.
AMD Stock Just Slipped Before Nvidia’s Big Test — Here’s What Changed

AMD Stock Just Slipped Before Nvidia’s Big Test — Here’s What Changed

19 May 2026
AMD shares fell 1.6% to $414.05 Tuesday after a volatile session, as investors trimmed chip stock holdings ahead of Nvidia’s earnings and rising Treasury yields pressured tech names. Citi raised its AMD price target to $460 but maintained a Neutral rating. Nvidia, down 0.7%, will report results Wednesday, with options implying a $355 billion market value swing. Intel rose 2.4%.
Go toTop